TaiCoo Biologics Q4 2025 Financials
Key facts
- TaiCoo Biologics Q4 2025 Financials
- TaiCoo Biologics Inc. reported an operating revenue of NT.005 billion and a net loss of NT61 million for Q4 2025, with basic EPS at -NT.51.
- Source: PR Times
- Date: December 1, 2025
Direct answer
TaiCoo Biologics Inc. reported an operating revenue of NT.005 billion and a net loss of NT61 million for Q4 2025, with basic EPS at -NT.51.
- Citation
- TaiCoo Biologics Q4 2025 Financials (December 1, 2025), PR Times
- Source
- PR Times
- Date
- December 1, 2025
TaiCoo Biologics Inc. reported an operating revenue of NT.005 billion and a net loss of NT61 million for Q4 2025, with basic EPS at -NT.51.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:21 (16h 20m after Collected)
Company Code: 6589. Company Name: TaiCoo Biologics Inc. Industry: Biotechnology and Medical Industry. Year/Quarter: 2025 Q4. Basic Earnings Per Share: -NT.51. Operating Revenue: NT.005 billion. Net Income After Tax: -NT61 million.
FAQ
What are the key facts in this article?
TaiCoo Biologics Inc. reported an operating revenue of NT.005 billion and a net loss of NT61 million for Q4 2025, with basic EPS at -NT.51.
What is the direct answer?
TaiCoo Biologics Inc. reported an operating revenue of NT.005 billion and a net loss of NT61 million for Q4 2025, with basic EPS at -NT.51.
What is the source and date?
PR Times: https://openapi.twse.com.tw/financial/twse-fin-6589-2025Q4 | December 1, 2025